Introduction
Elizabethkingia miricola, originally identified in 2004 in the Mir Space Station, belongs to the genus Elizabethkingia (previously Chryseobacterium) that contains four species of ubiquitous Gram-negative non-fermenting rods [1, 2] . Elizabethkingia meningoseptica mainly, and more recently E. miricola and Elizabethkingia anophelis, have been incriminated in severe infections in humans. Elizabethkingia endophytica is the last identified species of this genera; its pathogenic potential towards humans still remains undetermined [3] . Elizabethkingia meningoseptica has been involved in a broad range of infections in humans, including bacteraemia and meningitis, in particular in newborns and children where a high rate (84%) of meningitis has been documented. Noteworthy, nosocomial infections such as ventilator-associated pneumonia and haemodialysis catheter-related infections are a significant part of E. meningoseptica-related infections.
Elizabethkingia anophelis, initially isolated from the midgut of the mosquito malaria vector Anopheles gambiae [4] , has also been associated with similar severe infections (pneumonia, catheter-related infection and central nervous system infections) with high mortality rates [5, 6] . Elizabethkingia miricola has been recently incriminated in bacteraemia and sepsis both in immunocompetent and immunocompromised patients, supporting the clinical relevance of this strain [7] [8] [9] [10] . The strain E. miricola EM_CHUV described here was isolated from a lower respiratory tract specimen in the setting of severe nosocomial pneumonia. Antibiotic susceptibility testing of isolate EM_CHUV revealed a multidrug-resistant (MDR) profile, a phenotype encountered in most of the previously documented E. miricola strains. To better understand the genetic basis of this multidrug resistance, in this study the genome of EM_CHUV was sequenced and a genomics analysis was performed, including a comparison with the genomes of E. meningoseptica and E. anophelis.
Materials and methods

Microbiology procedures
Strain E. miricola EM_CHUV was recovered from the endotracheal secretions and bronchoalveolar lavage fluid of a patient. Isolate identification and antibiotic susceptibility testing, including detection of carbapenemase production, were performed as described in the Supplementary materials and methods.
Genome sequencing and analysis
Genomic DNA of E. miricola EM_CHUV was sequenced, assembled and annotated as described in the Supplementary materials and methods. The genome sequences of E. miricola ATCC 33958 type strain (JRFN00000000.1) [11] , E. anophelis NUHP1 (CP007547), E. anophelis R26 (ANIW00000000), E. meningoseptica ATCC 13253 (BARD01000018) and E. meningoseptica 502 (AVCQ00000000) were retrieved from the National Center for Biotechnology Information (NCBI) database and were annotated using RAST server [12] . The phylogenetic relationship among the Elizabethkingia spp. and closely related bacteria was based on the 16S rRNA genes. The resistome of EM_CHUV was investigated from the RAST annotation and was confirmed by BLASTP analysis against the ARG-ANNOT database [13] as well as information from the CARD database [14] in light of the antibiotic resistance phenotype. To address the putative foreign origin of resistance genes, we searched for the presence of genes harbouring domains of mobile elements within the annotation (transposase, integrase, insertion sequence and recombinase), genomic islands predicted with IslandViewer 3 [15] and prophages predicted using PHASTER [16] in their close vicinity. The absence of CRISPR domain sequences was identified using CRISPRFinder [17] . Average genome identity was evaluated using JSpecies v.1.2.1 [18] . Furthermore, the core proteomes were compared using GET_HOMOLOGUES [19] .
Results
Isolation of Elizabethkingia miricola EM_CHUV
In April 2014, an 82-year-old man was admitted to the intensive care unit (ICU) of University Hospital of Lausanne (Lausanne, Switzerland). The medical history of the patient started a year before with cervical spine surgery complicated by post-operative tetraparesia, which was followed by several hospitalisations for the management of recurrent pneumonia. The patient was initially treated by amoxicillin/clavulanic acid, followed by a combination of moxifloxacin and ceftazidime, and finally by amikacin and imipenem. At admission to our hospital, two pairs of blood bottles were drawn from an arterial catheter and were processed using a BD BACTEC TM FX automated blood miricola strain was also recovered by culture from the bronchoalveolar lavage fluid (10 7 bacteria/mL). Blood cultures remained sterile after 5 days of incubation. The recent literature has reported several cases of severe infections in humans owing to this organism, including pulmonary abscess and sepsis [7] [8] [9] [10] . These cases as well as the case described here are summarised in Table 1 and support a significant pathogenic potential of this organism.
Antibiotic susceptibility profile of Elizabethkingia miricola EM_CHUV
Antibiotic susceptibility testing performed on the S. maltophilia strain revealed sensitivity to minocycline, trimethoprim/sulfamethoxazole and levofloxacin. Elizabethkingia miricola EM_CHUV was found to be resistant to almost all of the antibiotic families tested, including β-lactams (ticarcillin/clavulanic acid, piperacillin/tazobactam, ceftazidime, cefepime, aztreonam, imipenem and meropenem), aminoglycosides (netilmicin and tobramycin) and colistin ( Table 2) . EM_CHUV was sensitive to the aminoglycosides gentamicin and amikacin and to minocycline. Susceptibility to levofloxacin but resistance to ciprofloxacin was also observed. A carbapenemase was detected using the rapid Carba NP test [20] and was characterised as a metallo-β-lactamase (MBL) using MBL Etest strips (MBL IP/IPI; bioMérieux, Lyon, France) by comparison of differential inhibition with and without ethylene diamine tetra-acetic acid (EDTA) as chelator in the presence of imipenem ( Supplementary Fig. S1 ) [21] . Thus, EM_CHUV exhibited a MDR phenotype, already documented for other E. miricola species, which we investigated through a genomic analysis.
Comparative genomics and phylogeny of the Elizabethkingia spp.
The general features of the genome of EM_CHUV and the other genomes included in this study are given in Supplementary Table S1 . The genome size of E. miricola EM_CHUV was estimated to be 4 286 503 bp with a GC content of 35.78%. A putative plasmid (pEM_CHUV) of 176 107 bp with a GC content of 40.15% was also identified, which encodes two full copies of the conjugative transposon operon tra (11 525 bp and 13 394 bp), likely involved in bacterial plasmid transmission by conjugation [22] . This plasmid showed no similarity to the complete genome of E. miricola BM10, but some regions shared similarity with different contigs of E. miricola ATCC 33958, suggesting that a similar plasmid could be found in various strains as an epitope or integrated within the genome. Interestingly, no resistance genes were detected on pEM_CHUV.
The phylogenetic tree of the 16S rRNA gene revealed that the three E. miricola strains constitute a monophyletic cluster distinct from the other Elizabethkingia spp. (Fig. 1A ).
As expected, E. miricola ATCC 33958 was the most closely related strain to EM_CHUV when considering whole-genome nucleotide identity and core proteome identity ( Fig.   1A,B ; Supplementary Fig. S2 ). In contrast, E. anophelis, E. meningoseptica and Chryseobacterium meningoseptica strains grouped together, suggesting that the current taxonomy does not appropriately reflect their phylogenetic relationships. The very close genetic proximity of E. anophelis NUPH1, E. anophelis R26 and E. meningoseptica 502 was confirmed by pairwise genome comparison (>97% identity) as well as by analysis of the core proteomes (>96% identity) ( Supplementary Fig. S2 ). Moreover, the group is paraphyletic due to the deeper branching of E. meningoseptica ATCC 13253, which suggests that the latter strain might belong to a different species. This finding was also supported by the low average genome nucleotide identity (78%) and average core proteome identity (84%) of E. meningoseptica ATCC 13253 with the other genomes ( Fig. 1B; Supplementary Fig. 2 ). Finally, over three-fold more proteins are shared between E. miricola EM_CHUV and E. anophelis NUHP1 (448 proteins) than E. miricola EM_CHUV and E. meningoseptica ATCC 13253 (134 proteins) (see Fig. 1C ). In congruence with our findings, the classification of E. meningoseptica 502 has been changed to E. anophelis 502 in NCBI taxonomy during the revision process of this article.
As depicted in Fig. 1C , the core proteome of E. miricola EM_CHUV, E. anophelis NUPH1 and E. meningoseptica ATCC 13253 consists of 2842 proteins. EM_CHUV encodes 254 strain-specific proteins mainly with an unknown function (214/254; 84.25%). Interestingly, annotated proteins include a type I restriction-modification system (RMS), a DNA mismatch repair (mutT) gene, a heavy metal transporter and a gene encoding for a colicin-like protein, a cytotoxin with bactericidal activity.
Resistome of Elizabethkingia miricola EM_CHUV
The resistome of EM_CHUV revealed a total of 40 antibiotic resistance genes (Table 2 ; Supplementary Table S2 ). A high number of genes (n = 20) are involved in resistance to β-lactams, including the bla GOB-13 and blaB-9 genes encoding for class B carbapenemases [23] . The genome of EM_CHUV also contains the aminoglycoside 6adenylyltransferase gene (ant-6) associated with tobramycin resistance. Furthermore, four genes associated with resistance to sulfonamides and six genes associated with resistance to macrolides could be identified. Four tetracycline resistance genes were also present. Finally, the resistome of the EM_CHUV isolate contained a chloramphenicol resistance gene. Analysis of the genes associated with resistance to quinolones revealed the mutation T83S of GyrA, M437L of GyrB and M437F/A473L of ParE; no mutation was found in ParC. None of the resistance genes were located on the putative plasmid pEM_CHUV. Noteworthy, the genome of E. miricola ATCC 33958 and the other Elizabethkingia genomes analysed in this study also contained all these genes, except for four β-lactamase genes ( Supplementary Table S2 ) [11] .
We investigated whether the resistance determinants could have been acquired horizontally as part of genomic islands, but very few mobile elements located close to the resistance genes were identified. Indeed, among the 12 mobile elements (transposases, integrases, insertion sequences and recombinases) found in the genome of EM_CHUV, only 2 were located in the proximity of a class C β-lactamaseencoding gene and a chloramphenicol acetyltransferase-encoding gene (at 5.6 kb and 1.1 kb, respectively). The four genomic islands predicted along the chromosome did not contain any resistance genes, and no prophages or CRISPR sequences were found.
Despite the presence of two tra operons likely encoding for a conjugative DNA transfer system on the plasmid that could favour genetic exchange, this bacterium could partially limit the integration of exogenous DNA owing to RMSs. Indeed, ten genes belonging to RMSs were identified, including four copies of the type I DNA methyltransferase gene, four copies of the type I specificity domain and two copies of the type I restriction endonuclease gene.
Discussion
In this study, the genome of the clinical isolate E. miricola EM_CHUV was sequenced and analysed with the aim of identifying the genetic basis of the MDR phenotype of this emerging pathogen. Such a MDR phenotype, including resistance to carbapenems, has also recently been documented for several other E. miricola strains incriminated in human infections [8] [9] [10] . Genome analysis of E. miricola EM_CHUV revealed the presence of a high number of genes involved in resistance to antibiotics (β-lactamases, aminoglycoside 6-adenylyltransferase, and sulfonamide, tetracycline and chloramphenicol resistance genes) that were not associated with mobile elements.
Moreover, all except four resistance genes were found to be conserved and most similar to orthologues in other E. miricola strains and other Elizabethkingia spp.
Altogether, these data suggested that the observed MDR phenotype of E. miricola EM_CHUV might be an intrinsic characteristic of this species and might be common within the Elizabethkingia genera.
Isolation of E. miricola EM_CHUV in the setting of nosocomial pneumonia in this study, together with two other documentations of E. miricola occurring in the setting of severe infections (bacteraemia and sepsis) involving respiratory tract infections [8, 9] , raises the question of a pulmonary tropism of this micro-organism. Similar to what is being described for E. meningoseptica and E. anophelis, such a tropism might be associated with increased risk of nosocomial pneumonia and more generally of nosocomial infection, which is further supported by the fact that in most reported cases the patient becomes colonised by E. miricola following broad-spectrum antibiotic treatment.
Overall, this study supports that E. miricola be considered as a potential pathogen with significant nosocomial risk based on frequent MDR phenotypes. Novel accurate identification methods such as MALDI-TOF/MS might reveal the true incidence of this bacterium. As a consequence, particular attention should be paid to this pathogen when isolated from clinical samples, and antibiotic susceptibility testing should be systematically performed.
Sequence accession no.
The Whole Genome Shotgun project of E. miricola EM_CHUV has been deposited at DDBJ/EMBL/GenBank under the accession no. LIQC00000000. 
